No association between anxiety disorders and catechol-O-methyltransferase polymorphism.
Several studies have shown that the morbidity risk for anxiety disorders is increased among the relatives of patients with obsessive-compulsive disorder (OCD). Recently, it was reported that a polymorphism of the catechol-O-methyltransferase (COMT) gene is significantly associated with OCD. The purpose of this study was to determine the association, if any, between the COMT polymorphism and anxiety disorders. We undertook an association study of the COMT polymorphism in 108 patients who met DSM-IV criteria for anxiety disorders and 135 healthy controls. All subjects were unrelated Japanese. The subdiagnostic groups did not differ significantly from the control group in either the genotypic or allelic frequencies. There were no statistically significant differences between the genotype and males, females, or a family history. The mean age of onset did not significantly differ among the genotypes. Our results suggest this functional COMT polymorphism does not make an important contribution to anxiety disorders in the Japanese population.
Ohara
K
K
Department of Psychiatry, Hamamatsu University School of Medicine, Shizuoka, Japan.
Nagai
M
M
Suzuki
Y
Y
Ochiai
M
M
Ohara
K
K
D000328:Adult; D000483:Alleles; D001008:Anxiety Disorders / Q000201:enzymology* / Q000235:genetics; D002394:Catechol O-Methyltransferase / Q000235:genetics*; D005260:Female; D005838:Genotype; D006801:Humans; D008297:Male; D016584:Panic Disorder / Q000201:enzymology / Q000235:genetics; D010698:Phobic Disorders / Q000201:enzymology / Q000235:genetics; D011110:Polymorphism, Genetic
D002394:Catechol O-Methyltransferase